09:50 AM EDT, 09/11/2024 (MT Newswires) -- Applied DNA Sciences ( APDN ) shares were surging more than 24% in early Wednesday trading after the company said it was expanding its clinical testing services to include the detection of Mpox Clade I and Clade II.

The expanded testing capabilities follow the company's interactions with the New York State Department of Health, the US Food and Drug Administration and other relevant regulatory bodies, it said.

Price: 1.60, Change: +0.32, Percent Change: +24.61